According to Coherent Market Insights, Global Cancer supportive care products Market is estimated to be valued at US$ 32,458.0 million in 2023 and is expected
Organ-on-chip (OOC) devices combine advanced cell cultures with microengineering to create cutting-edge biotechnology promising to revolutionize sectors from drug development to chemical risk assessment.